(Total Views: 126)
Posted On: 10/07/2020 10:43:34 AM
Post# of 98437

$NBIO’s top asset is Pritumumab which targets brain, lung, breast, and pancreatic cancer
https://biopharmajournal.com/2020/09/29/why-n...close-look
https://biopharmajournal.com/2020/09/29/why-n...close-look


Scroll down for more posts ▼